AI-generated summary
The authors report a double-blind randomized trial comparing 15 post-stroke patients with spastic hemiparesis who received 10 sessions of photobiomodulation with 12 healthy controls. They report a 38% reduction in self-reported pain, a decrease in blood lactate, and a 46.1% increase in elbow extension range of motion in the paretic limb after treatment, while muscle torque was higher in the control group.
- Participants
- 27
- Who or what was studied
- Post-stroke adults with spastic hemiparesis (PBM group, n = 15) and healthy individuals (control group, n = 12)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract does not report a between-group comparison of the treatment effect and gives no statistical detail on the pain, lactate and range-of-motion changes, so the findings should be interpreted cautiously.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Energy density (fluence)
- 127.4 J/cm2
- Total energy
- 4 J, 64 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Stroke, Visual analogue scale, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.